Form 4: Outset Medical General Counsel Sells Shares for Tax Cover

Outset Medical's General Counsel, John L. Brottem, sold 2,842 shares of common stock to cover tax withholding obligations related to RSU vesting.

Summary

• John L. Brottem, General Counsel of Outset Medical, Inc. (OM), reported a transaction involving the company's common stock.
• On February 17, 2026, Brottem sold 2,842 shares of common stock at a price of $3.35 per share.
• This sale was a 'sell to cover' transaction, specifically executed to satisfy partial tax withholding obligations.
• The tax obligations arose from the vesting of an aggregate of 5,032 shares of common stock underlying Restricted Stock Units (RSUs).
• These RSUs were granted to Brottem on January 12, 2024, and June 10, 2025.
• The transaction was not a discretionary trade by the reporting person.
• Following this reported transaction, John L. Brottem beneficially owns 32,935 shares of Outset Medical common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it's a non-discretionary sale for tax purposes rather than an indication of management's sentiment about the company's valuation or future performance.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are a common and routine practice for executives receiving equity compensation. These sales are typically non-discretionary and are executed solely to satisfy tax withholding obligations upon the vesting of restricted stock units or other equity awards. As such, they are generally not interpreted as an indicator of management's sentiment regarding the company's future performance or stock valuation, unlike open market discretionary sales.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, non-discretionary transaction for tax purposes and does not reflect a change in management's investment outlook.

Key Dates

Recommendation

This Form 4 reports a routine 'sell to cover' transaction by an executive to satisfy tax obligations related to RSU vesting. It is not a discretionary sale and therefore does not typically signal a change in management's outlook or warrant a change in investment recommendation based solely on this filing.

Keywords

Outset Medical, OM, Form 4, Insider Transaction, Stock Sale, General Counsel, John L. Brottem, RSU, Sell to Cover, Tax Withholding